Working With India To Improve Drug Quality, Safety: USFDA

Mumbai: The U.S. Food and Drug Administration (USFDA) said it was working with regulators to enhance the quality and safety of drugs as 40 per cent of generic drugs exported to America were from India.

Margaret Hamburg, the visiting Commissioner of the U.S. health regulator, termed India as a very important partner for her country in the pharma sector.

"India is a very important partner and nearly 40 per cent generic drugs in the U.S. come from India. Indian pharma industry is leader in many areas. They need to meet the standards and expectations of American regulatory system and we want to work with them. We need to work together to ensure quality and safety," Hamburg told reporters here at the end of her first official trip to India.

"If Indian pharma companies want to sell in the U.S., they need to comply with our standards, practices and expectations. By working together we can enhance quality and better ensure the health of public," she said in response to queries over FDA decision to ban leading pharma players like Ranbaxy and Wockhardt for not following quality standards.
Read Also:
Lawmakers Turn Lawbreaker: World's Worst Parliamentary Clashes
Rajiv Killers' Death Sentence Commuted To Life Imprisonment